™Your Policy Risk Impact Agent
55 chapters · 1,410 sections in this title.
A.R.S. § 36-1331 Definitions
4.2K chars
In this chapter, unless the context otherwise requires: 1. "Eligible facility" means a health care institution that operates under a federalwide assurance for the protection of human subjects pursuant to 45 Code of Federal Regulations part 46 and that is subject to the federal fe…
A.R.S. § 36-1332 Individualized investigational treatment; availability
1.0K chars
A. A manufacturer operating within an eligible facility and pursuant to all applicable federalwide assurance regulations may make available to an eligible patient an individualized investigational treatment. An eligible patient's physician may request an individualized investigat…
A.R.S. § 36-1333 Insurance providers; third-party payors; coverage or payment not required
0.6K chars
A. A health plan, third-party administrator or other third-party payor may, but is not required to, provide coverage for the cost of an individualized investigational drug, biological product or device or the cost of services related to the use of an individualized investigationa…
A.R.S. § 36-1334 Heirs; no debt liability related to treatment
0.2K chars
Notwithstanding any other law, if a patient dies while being treated with an individualized investigational drug, biological product or device, the patient's heirs are not liable for any outstanding debt related to the treatment.